Researchers are linking data from the 34,000 patients in the IBD BioResource to COVID-19 testing data from Public Health England to explore the impact of IBD medications on the risk of COVID-19 infection and severe disease.
Although currently paused due to COVID-19, the IBD BioResource will re-open to new recruits soon. Keep an eye on their website and social media this to find out when you can join!
When will the findings of this work come out? Results are due to come out in autumn/winter 2020.
Lead researchers: Dr Miles Parkes (Cambridge University Hospitals), Dr Neil Walker, (NIHR BioResource), Dr Nick Kennedy (Royal Devon & Exeter Hospital).